Showing 1 - 10 of 24,906
We examine how R&D portfolios of drug pipelines affect pharmaceutical licensing, controlling firm size, diversity, and … between 1997 and 2007. We pay special attention to stage-specific licensing by dividing the innovation process into early and … pipelines significantly affect stage-specific licensing, inducing portfolio effect that lead to smoothing drug pipelines across …
Persistent link: https://www.econbiz.de/10010785083
Persistent link: https://www.econbiz.de/10010465082
In the pharmaceutical industry, firms frequently engage in licensing agreements to overcome innovation challenges and … keep up with the pace of developing new drugs. Licensing helps firms jointly develop new drugs and acquire external … knowledge, which helps improve their internal drug development capability. Our study examines the dynamic effects of licensing …
Persistent link: https://www.econbiz.de/10012219514
, has been a focus for these large MNC's scouting for licensing new drugs. This work analyses the licensing activities that …
Persistent link: https://www.econbiz.de/10012994958
In the pharmaceutical industry, firms frequently engage in licensing agreements to overcome innovation challenges and … keep up with the pace of developing new drugs. Licensing helps firms jointly develop new drugs and acquire external … knowledge, which helps improve their internal drug development capability. Our study examines the dynamic effects of licensing …
Persistent link: https://www.econbiz.de/10012832198
There are several determinants that could have an effect on in-licensing decisions by a pharmaceutical or biotech firm …. This work studies over 200 licensing deals involving big pharma companies in the period (2011 – 2015) and identifies … different factors that could play a role in licensing deals, and classifies these determinants into direct determinants and …
Persistent link: https://www.econbiz.de/10014033016
Our study puts special attention to the fact that R&D cooperations in the pharmaceutical industry are formed at different stages throughout the drug development process. We study if the timing to engage in R&D cooperations in the pharmaceutical industry has different impacts on the technology...
Persistent link: https://www.econbiz.de/10010229875
In the pharmaceutical industry, firms frequently engage in licensing agreements to overcome innovation challenges and … keep up with the pace of developing new drugs. Licensing helps firms jointly develop new drugs and acquire external … knowledge, which helps improve their internal drug development capability. Our study examines the dynamic effects of licensing …
Persistent link: https://www.econbiz.de/10012227651
We evaluate the welfare effects of differential pricing, voluntary licensing, and compulsory licensing in the Indian … as under counterfactual policy scenarios such as compulsory licensing whereby the government forcibly assigns the right … pricing and licensing strategies by the patent holders. Our results indicate that differential pricing and voluntary licensing …
Persistent link: https://www.econbiz.de/10013035611
of competition between potential buyers has countervailing effects on this condition. An empirical analysis of licensing …
Persistent link: https://www.econbiz.de/10008854505